Skip Ribbon Commands
Skip to main content
Sign In

25624 T-Cell Receptor Gene Rearr, PCR, Varies (TCGRV)

T-Cell Receptor Gene Rearr, PCR, Varies (TCGRV)
Test Code: TCGRVSO
Synonyms/Keywords
​​Lymphoma vs Benign Process, Reactive Lymphocytic Process, T-Cell Gene Rearrangement, TCGRV, T Cell Gene Rearrangement, T Cell Clonality
Useful For
Determining whether a T-cell population is polyclonal or monoclonal
Specimen Requirements
Specimen Type Preferred Container/Tube Acceptable Container/Tube Specimen Volume Specimen Minimum Volume
(allows for 1 repeat)
Pediatric Minimum Volume
(no repeat)
​Body Fluid ​Sterile Container ​5 mL ​1 mL
​Paraffin-embedded bone marrow aspirate clot ​Paraffin block
​Frozen Tissue ​Plastic Container ​100 mg ​50 mg
​Paraffin-embedded tissue ​Paraffin block
​Spinal fluid ​Sterile Vial ​10 mL ​1 mL
​Extracted DNA from blood or bone marrow ​1.5 to 2 mL tube with indication of volume and concentration of DNA ​Entire Specimen ​50 microliter at
20 ng/mcL


​Tissue slides
​Unstained tissue slides


​10 slides
Collection Processing Instructions
Body fluid or spinal fluid specimens must arrive within 4 days (96 hours) of collection.

If sending body fluid:
1. If the volume is large, pellet cells prior to sending.
2. Send less volume at ambient temperature or as a frozen cell pellet.

Include Hematopathology Patient Information Sheet.
(http://www.mayomedicallaboratories.com/it-mmfiles/hematopathology-request-form.pdf)
Specimen Stability Information

Specimen Type

​Temperature
​Tissue slides
​​Ambient
​Body Fluid ​ ​ ​Ambient
​Refrigerate
​Frozen
​Cell Pellet ​Frozen
​Paraffin-embedded bone marrow aspirate clot ​ ​Ambient
​Frozen Tissue ​Frozen
​Parrafin-embedded tissue ​ ​ Ambient
​Spinal Fluid ​ Ambient
​Refrigerate
​Extracted D​NA from blood or bone marrow ​ Ambient
​Refrigerate
Rejection Criteria
Bone marrow core biopsies or paraffin shavings
Interference

To determine the significance of the result, it must always be interpreted in the context of other clinicopathologic information.

The interpretation of the presence or absence of a predominant T-cell receptor (TCR)-gene rearrangement profile is sometimes subjective.

The detection of a clonal TCR-gene rearrangement by this test is not necessarily synonymous with the presence of a T-cell neoplasm. False-positive results can occur because of the sensitivity of polymerase chain reaction (PCR) technique and the problem of nonuniform (skewed) amplification of target T-cell gene rearrangements. The latter problem can occur when the total T-cell number in a sample is limited, or because of physiologic skewing of the T-cell repertoire as seen with aging, posttransplantation, or T-cell reactions in autoimmune or (nonlymphoid) malignancies. False-negative results can occur for many reasons, including tissue sampling, poor amplification, or failure to detect a small minority of T-cell gene segment rearrangements with the use of consensus PCR primers. In some cases, an indeterminate or equivocal result will occur because the pattern of gene rearrangements is abnormal (compared to typical polyclonal T-cell processes), but not definitive, for a monoclonal T-cell population. In these situations, distinction of a small monoclonal subpopulation from an over-represented, but reactive, population may not be possible.

Performing Laboratory Information
Performing Location Day(s) Test Performed Report Available
Methodology/Instrumentation
​Mayo Clinic Laboratories ​Monday through Friday ​7-14 days Polymerase Chain Reaction (PCR)
Test Information

The T-cell receptor (TCR) genes (alpha, beta, delta, and gamma) are comprised of numerous, discontinuous coding segments that somatically rearrange to produce heterodimeric cell surface TCR, either alpha/beta (90%-95% of T cells) or gamma/delta (5%-10% of T cells). With rare exceptions (eg, some neoplastic B-lymphoid proliferations), other cell types retain the germline configuration of the TCR genes without rearrangement.

The marked diversity of somatic TCR-gene rearrangements is important for normal immune functions but also serves as a valuable marker to distinguish abnormal T-cell proliferations from reactive processes. A monoclonal expansion of a T-cell population will result in the predominance of a single TCR-gene rearrangement pattern. In contrast, reactive T-cell expansions are polyclonal (or multiclonal), with no single clonotypic population predominating in the population of T cells. These distributive differences in both TCR sequence and genomic rearrangement fragment sizes can be detected by molecular techniques (ie, polymerase chain reaction) and used to determine if a population of T cells shows monoclonal or polyclonal features.

Reference Range Information
Performing Location Reference Range
​Mayo Clinic Laboratories ​Positive, negative, or indeterminate for a clonal T-cell population
Interpretation
An interpretive report will be provided. Results will be characterized as positive, negative, or indeterminate for a clonal T-cell population. In the appropriate clinicopathologic setting, a monoclonal result is associated with a neoplastic proliferation of T cells.
Outreach CPTs
CPT Modifier
(if needed)
Quantity Description Comments
​81340 ​TCB gene rearrangement, PCR
​81342 ​​TCG at gene rearrangement analysis
Classification
Synonyms/Keywords
​​Lymphoma vs Benign Process, Reactive Lymphocytic Process, T-Cell Gene Rearrangement, TCGRV, T Cell Gene Rearrangement, T Cell Clonality
Ordering Applications
Ordering Application Description
​COM ​T-Cell Receptor Gene Rearr, PCR, Varies (TCGRV)​

​Cerner
​T-Cell Receptor Gene Rearr, PCR, Varies (TCGRV)
If the ordering application you are looking for is not listed, contact your local laboratory for assistance.
Specimen Requirements
Specimen Type Preferred Container/Tube Acceptable Container/Tube Specimen Volume Specimen Minimum Volume
(allows for 1 repeat)
Pediatric Minimum Volume
(no repeat)
​Body Fluid ​Sterile Container ​5 mL ​1 mL
​Paraffin-embedded bone marrow aspirate clot ​Paraffin block
​Frozen Tissue ​Plastic Container ​100 mg ​50 mg
​Paraffin-embedded tissue ​Paraffin block
​Spinal fluid ​Sterile Vial ​10 mL ​1 mL
​Extracted DNA from blood or bone marrow ​1.5 to 2 mL tube with indication of volume and concentration of DNA ​Entire Specimen ​50 microliter at
20 ng/mcL


​Tissue slides
​Unstained tissue slides


​10 slides
Collection Processing
Body fluid or spinal fluid specimens must arrive within 4 days (96 hours) of collection.

If sending body fluid:
1. If the volume is large, pellet cells prior to sending.
2. Send less volume at ambient temperature or as a frozen cell pellet.

Include Hematopathology Patient Information Sheet.
(http://www.mayomedicallaboratories.com/it-mmfiles/hematopathology-request-form.pdf)
Specimen Stability Information

Specimen Type

​Temperature
​Tissue slides
​​Ambient
​Body Fluid ​ ​ ​Ambient
​Refrigerate
​Frozen
​Cell Pellet ​Frozen
​Paraffin-embedded bone marrow aspirate clot ​ ​Ambient
​Frozen Tissue ​Frozen
​Parrafin-embedded tissue ​ ​ Ambient
​Spinal Fluid ​ Ambient
​Refrigerate
​Extracted D​NA from blood or bone marrow ​ Ambient
​Refrigerate
Rejection Criteria
Bone marrow core biopsies or paraffin shavings
Interference

To determine the significance of the result, it must always be interpreted in the context of other clinicopathologic information.

The interpretation of the presence or absence of a predominant T-cell receptor (TCR)-gene rearrangement profile is sometimes subjective.

The detection of a clonal TCR-gene rearrangement by this test is not necessarily synonymous with the presence of a T-cell neoplasm. False-positive results can occur because of the sensitivity of polymerase chain reaction (PCR) technique and the problem of nonuniform (skewed) amplification of target T-cell gene rearrangements. The latter problem can occur when the total T-cell number in a sample is limited, or because of physiologic skewing of the T-cell repertoire as seen with aging, posttransplantation, or T-cell reactions in autoimmune or (nonlymphoid) malignancies. False-negative results can occur for many reasons, including tissue sampling, poor amplification, or failure to detect a small minority of T-cell gene segment rearrangements with the use of consensus PCR primers. In some cases, an indeterminate or equivocal result will occur because the pattern of gene rearrangements is abnormal (compared to typical polyclonal T-cell processes), but not definitive, for a monoclonal T-cell population. In these situations, distinction of a small monoclonal subpopulation from an over-represented, but reactive, population may not be possible.

Useful For
Determining whether a T-cell population is polyclonal or monoclonal
Reference Range Information
Performing Location Reference Range
​Mayo Clinic Laboratories ​Positive, negative, or indeterminate for a clonal T-cell population
Interpretation
An interpretive report will be provided. Results will be characterized as positive, negative, or indeterminate for a clonal T-cell population. In the appropriate clinicopathologic setting, a monoclonal result is associated with a neoplastic proliferation of T cells.
For more information visit:
Performing Laboratory Information
Performing Location Day(s) Test Performed Report Available
Methodology/Instrumentation
​Mayo Clinic Laboratories ​Monday through Friday ​7-14 days Polymerase Chain Reaction (PCR)
For billing questions, see Contacts
Outreach CPTs
CPT Modifier
(if needed)
Quantity Description Comments
​81340 ​TCB gene rearrangement, PCR
​81342 ​​TCG at gene rearrangement analysis
Classification
For most current information refer to the Marshfield Laboratory online reference manual.